Epidemiology and prevention of pancreatic cancer
- PMID: 15231857
- DOI: 10.1093/jjco/hyh045
Epidemiology and prevention of pancreatic cancer
Abstract
Pancreatic cancer is an uncommon tumor, but because the mortality rate approaches 100%, this form of cancer has now become a common cause of cancer mortality. In the United States it is the fourth most frequent cause of cancer mortality; in Japan it ranks as the fifth commonest cause of death from cancer. Smoking is the major known risk factor for pancreatic cancer, accounting for approximately 25-30% of all cases. Some of the time-dependent changes in the frequency of pancreatic cancer can be explained by smoking trends. Aggressive public health measures to control smoking would substantially reduce the burden of pancreatic cancer. Dietary factors are less important for pancreatic cancer than for other digestive tract tumors, but consumption of a diet with adequate quantities of fruits and vegetables, plus control of calories either by dietary measures or by exercise will help to prevent this lethal tumor. There are more than a dozen inherited germline mutations that increase the risk of pancreatic cancer. Of these, hereditary pancreatitis confers the greatest risk, while BRCA2 mutations are the commonest inherited disorder. In addition to germline defects, there are several common polymorphisms in genes that control detoxification of environmental carcinogens that may alter the risk of pancreatic cancer. More research will be needed in this area, to explain and to clarify the interaction between genes and environmental factors.
Similar articles
-
[The epidemiology of pancreatic cancer].Orv Hetil. 2010 Oct 31;151(44):1816-22. doi: 10.1556/OH.2010.28986. Orv Hetil. 2010. PMID: 20961843 Review. Hungarian.
-
[Advances in researches on genetic epidemiology of pancreatic cancer].Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Apr;28(2):289-93. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006. PMID: 16733922 Review. Chinese.
-
Epidemiologic and etiologic factors of pancreatic cancer.Hematol Oncol Clin North Am. 2002 Feb;16(1):1-16. doi: 10.1016/s0889-8588(01)00003-x. Hematol Oncol Clin North Am. 2002. PMID: 12063821 Review.
-
Risk factors for pancreatic cancer.J Cell Biochem. 2005 Jul 1;95(4):649-56. doi: 10.1002/jcb.20461. J Cell Biochem. 2005. PMID: 15849724 Review.
-
Epidemiology of pancreatic cancer.Minerva Chir. 2004 Apr;59(2):99-111. Minerva Chir. 2004. PMID: 15238885 Review.
Cited by
-
Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents.Semin Immunopathol. 2013 Mar;35(2):203-27. doi: 10.1007/s00281-012-0340-x. Epub 2012 Sep 7. Semin Immunopathol. 2013. PMID: 22955327 Review.
-
The Roles of Mesenchymal Stem Cells in Gastrointestinal Cancers.Front Immunol. 2022 Feb 24;13:844001. doi: 10.3389/fimmu.2022.844001. eCollection 2022. Front Immunol. 2022. PMID: 35281017 Free PMC article. Review.
-
Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort.J Gastrointest Cancer. 2019 Dec;50(4):794-800. doi: 10.1007/s12029-018-0158-4. J Gastrointest Cancer. 2019. PMID: 30105523
-
Case-Control Trials on Risk Factors for Pancreatic Cancer: A Systematic Review and Meta-Analysis.Iran J Public Health. 2023 Aug;52(8):1578-1588. doi: 10.18502/ijph.v52i8.13397. Iran J Public Health. 2023. PMID: 37744539 Free PMC article. Review.
-
THE FREQUENCY OF RISK FACTORS ON TRENDS OF PANCREATIC CANCER IN KOSOVO.Mater Sociomed. 2016 Apr;28(2):108-11. doi: 10.5455/msm.2016.28.108-112. Epub 2016 Mar 25. Mater Sociomed. 2016. PMID: 27147915 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous